Suppr超能文献

噻嗪类及噻嗪样利尿剂在尿崩症中的反常抗利尿作用:一项系统评价

Paradoxical Anti-diuretic Effects of Thiazide and Thiazide-Like Diuretics in Diabetes Insipidus: A Systematic Review.

作者信息

Perrine Anne Laure A, Reechaye Driti, Banerjee Indrajit, Robinson Jared, Banerjee Indraneel

机构信息

Internal Medicine, Sir Seewosagur Ramgoolam Medical College, Belle Rive, MUS.

Pharmacology, Sir Seewoosagur Ramgoolam Medical College, Belle Rive, MUS.

出版信息

Cureus. 2025 Apr 14;17(4):e82247. doi: 10.7759/cureus.82247. eCollection 2025 Apr.

Abstract

Diabetes insipidus (DI) is a rare endocrine disorder predominantly characterized by polyuria, polydipsia, and dehydration, which can be defined as an excess of 3L of urine excretion in an adult over 24 hours, with the urine osmolality being less than 300 mosm/kg HO. Increased water loss from the body can lead to significant complications, including death, from severe dehydration. Hence, timely treatment of the disease to prevent and replace the fluid loss should be instituted.  Thiazide diuretics are the drugs used and act paradoxically in this particular situation. Thiazides and thiazide-like drugs have shown promising results in reducing the volume of urine output and enhancing urine osmolality in patients with nephrogenic diabetes. The mechanism by which thiazide diuretics are able to cause such a paradoxical effect is not well understood. This systematic review seeks to shed light to the details of the exact mechanism through which thiazides and thiazide-like drugs act in patients with DI, so as to bring positive changes in their overall health status and keep the water loss to a minimum.  Completed clinical trials, from January 1965 to January 2025, were included in the systematic review. Risk of bias was evaluated in each of the selected articles. The revised Cochrane risk-of-bias tool for randomized trials (RoB 2) with was used for the two crossover randomized controlled trials (RCTs) and the Risk of Bias In Non-randomized Studies - of Interventions, Version 2 (ROBINS-I V2) assessment tool was used to assess the risk of bias in the non-randomized controlled trials (NRCTs) included in the systematic review. The extensive literature search through PubMed, Cochrane Central Register of Controlled Trials (CENTRAL), and Trip databases resulted in a total of 524 articles screened for this systematic review. Ultimately, only five articles, including two RCTs and three NRCTs were included in this systematic review. It is evident that the counterintuitive use of thiazide diuretics in cases of diabetes insipidus is a tried, tested, and proven method to aid in the management of fluid control in such patients, with notable improvements being identified in urine osmolality as well as urine production over a 24-hour period. The exact mechanism by which each species of thiazide diuretic specifically brings about this paradoxical effect is not well established, but the ultimate pathway by which it reduces the urine output is via proximal tubular reabsorption of water and sodium.

摘要

尿崩症(DI)是一种罕见的内分泌疾病,主要特征为多尿、烦渴和脱水,成人24小时尿量超过3L且尿渗透压低于300 mosm/kg H₂O可定义为尿崩症。身体水分流失增加会导致严重并发症,包括因严重脱水而死亡。因此,应及时治疗该疾病以预防和补充液体流失。噻嗪类利尿剂是在这种特殊情况下使用的药物,其作用方式看似矛盾。噻嗪类和噻嗪样药物在减少肾性尿崩症患者尿量和提高尿渗透压方面已显示出有前景的结果。噻嗪类利尿剂产生这种矛盾效应的机制尚不清楚。本系统评价旨在阐明噻嗪类和噻嗪样药物在尿崩症患者中起作用的确切机制细节,以便改善他们的整体健康状况并将水分流失降至最低。纳入本系统评价的临床试验为1965年1月至2025年1月期间完成的试验。对每篇入选文章进行偏倚风险评估。对于两项交叉随机对照试验(RCT),使用修订后的Cochrane随机试验偏倚风险工具(RoB 2),对于系统评价中纳入的非随机对照试验(NRCT),使用干预性非随机研究中的偏倚风险评估工具(ROBINS-I V2)来评估偏倚风险。通过PubMed、Cochrane对照试验中心注册库(CENTRAL)和Trip数据库进行广泛的文献检索,共筛选出524篇文章用于本系统评价。最终,本系统评价仅纳入了五篇文章,包括两项RCT和三项NRCT。显然,在尿崩症病例中使用噻嗪类利尿剂这种与直觉相悖的方法是一种经过试验、验证且被证明有助于此类患者液体控制管理的方法,在尿渗透压以及24小时尿量方面都有显著改善。每种噻嗪类利尿剂具体产生这种矛盾效应的确切机制尚未完全明确,但它减少尿量的最终途径是通过近端肾小管对水和钠的重吸收。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验